Literature DB >> 20795316

A review of the Chido/Rodgers blood group.

R Mougey1.   

Abstract

The C4 protein plays an important role in maintaining health and, in some situations complicated by poor expression of the C4 protein, may lead to or exacerbate certain diseases. The blood groups Chido and Rodgers are epitopes on the C4 protein, and polymorphisms associated with these epitopes may lead to the formation of antibodies to the Chido or Rodgers antigens in transfused patients. Identification of anti-Ch or anti-Rg is still based on the antibody neutralization with plasma from Ch-positive or Rg-positive individuals and lack of reactivity with qualified Ch-negative or Rg-negative RBCs. These antibodies may be useful in genetic studies of C4 polymorphisms or, in the case of C4-deficient patients, a signal of the potential for serious illnesses. The recognition of the extreme polymorphism of the C4 gene and the gene complex RCCX should lead to more insights in the understanding of disease risk and potential treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20795316

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  5 in total

1.  Serum complement C4a and its relation to liver fibrosis in children with chronic hepatitis C.

Authors:  Behairy E Behairy; Ghada M El-Mashad; Ragab S Abd-Elghany; Enas M Ghoneim; Mostafa M Sira
Journal:  World J Hepatol       Date:  2013-08-27

2.  C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.

Authors:  E Nissilä; K Korpela; A I Lokki; R Paakkanen; S Jokiranta; W M de Vos; M-L Lokki; K-L Kolho; S Meri
Journal:  Clin Exp Immunol       Date:  2017-09-25       Impact factor: 4.330

3.  Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

Authors:  Riitta Paakkanen; Hanna Vauhkonen; Katja T Eronen; Asko Järvinen; Mikko Seppänen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

4.  Clinical features of patients with homozygous complement C4A or C4B deficiency.

Authors:  Inka Liesmaa; Riitta Paakkanen; Asko Järvinen; Ville Valtonen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

5.  Simulated RBC antibody identification training panels created using SARS-CoV-2 kodecytes and immune plasma.

Authors:  Holly Perry; Stephen M Henry
Journal:  Transfusion       Date:  2022-07-11       Impact factor: 3.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.